Fanconi Anemia: Symptoms, Causes, Diagnosis, and Treatment

Fanconi anemia (FA) is a rare inherited genetic disorder that affects the body's ability to repair damaged DNA. People with this condition have an increased risk of bone marrow failure, blood cancers, and certain solid tumors. Although Fanconi anemia is usually identified during childhood, some individuals are not diagnosed until adulthood.

Understanding Fanconi anemia symptoms, genetic causes, diagnosis, and available treatment options is important for early detection and long-term disease management. Although there is currently no treatment that corrects every aspect of the disorder, modern medical care can significantly improve blood cell production, manage complications, and reduce certain health risks.

In this article, Begin Health Life explains Fanconi anemia, where you can discover its early symptoms, genetic causes, diagnostic tests, treatment options, and potential complications, including bone marrow failure and increased cancer risk.

A child with Fanconi anemia, featuring a close-up circular illustration of a hand showing characteristic thumb and limb abnormalities associated with the genetic disorder.

What Is Fanconi Anemia?

Fanconi anemia is an inherited bone marrow failure syndrome characterized by defective DNA repair and increased chromosome instability. It primarily affects the bone marrow, where blood cells are produced, but can also interfere with normal growth, organ development, and immune function.

As these stem cells gradually become damaged or depleted, the bone marrow may lose its ability to maintain normal blood cell production. This can lead to pancytopenia, a condition in which all three major blood cell types become reduced.

The severity of Fanconi anemia varies considerably. Some affected individuals develop congenital abnormalities, while others have few noticeable physical features. Bone marrow failure may appear during childhood or develop later in life.

What Causes Fanconi Anemia?

Fanconi anemia develops because of pathogenic genetic variants in genes responsible for maintaining DNA stability. More than 20 genes have been associated with this condition. These genes participate in a coordinated DNA repair process known as the Fanconi anemia pathway. 

Its primary function is to repair a particular type of DNA damage called interstrand crosslinks. These crosslinks occur when chemical bonds form between the two strands of DNA, preventing them from separating properly during DNA replication.

Normally, specialized proteins recognize this damage, activate the Fanconi anemia pathway, and coordinate DNA repair with other cellular repair mechanisms. When this pathway does not function correctly, damaged DNA accumulates, chromosomes become unstable, and cells may die or develop abnormal genetic changes.

Most cases follow an autosomal recessive inheritance pattern, meaning a child generally inherits one defective copy of an associated gene from each parent. However, some forms involve X-linked or autosomal dominant inheritance.

Parents who carry one disease-associated variant generally do not develop Fanconi anemia themselves. Genetic counseling and carrier testing can help families understand their reproductive risks.

Symptoms and Early Signs of Fanconi Anemia

Fanconi anemia can affect multiple body systems, and symptoms differ depending on the genetic subtype and disease progression. Approximately 75% of affected individuals have one or more recognizable physical abnormalities.

Common Fanconi anemia symptoms include:

      • Abnormal skin pigmentation: Macules, darker skin patches, or areas of reduced pigmentation may appear.
      • Skeletal abnormalities: Underdeveloped or missing thumbs, abnormal forearm bones, and other limb malformations can occur.
      • Short stature: Children may experience slower-than-expected physical growth.
      • Small head size: Microcephaly may be present in some individuals.
      • Kidney and reproductive abnormalities: Structural kidney defects and genital or reproductive system abnormalities may occur.
      • Eye and ear abnormalities: Some individuals develop smaller eyes, vision problems, or hearing difficulties.

As bone marrow function declines, additional symptoms may develop:

      • Reduced red blood cell production (Anemia) can cause fatigue, weakness, pale skin, and shortness of breath.
      • Low platelet counts (Thrombocytopenia) can lead to easy bruising, nosebleeds, and prolonged bleeding.
      • Reduced neutrophil levels (Neutropenia) increase susceptibility to bacterial and fungal infections.

Some individuals initially have no obvious physical abnormalities. Therefore, the absence of congenital defects does not rule out Fanconi anemia.

How Is Fanconi Anemia Diagnosed?

Early diagnosis is important because Fanconi anemia requires specialized medical monitoring and treatment. Doctors may suspect the condition when congenital abnormalities occur alongside unexplained blood count abnormalities or a family history of inherited bone marrow failure.

Several diagnostic tests help confirm the condition.

1. Complete Blood Count (CBC): A CBC measures red blood cells, white blood cells, hemoglobin, and platelets. Unusually large red blood cells can be an early laboratory finding in Fanconi Anemia. Progressive reductions in blood cell counts may indicate developing bone marrow failure.

2. Chromosome Breakage Test: This is the standard diagnostic test for Fanconi anemia. Blood cells are exposed to DNA-damaging chemicals, particularly diepoxybutane (DEB), or mitomycin C (MMC). Cells affected by Fanconi anemia show increased chromosome breaks and characteristic abnormal chromosome arrangements called radial figures.

3. Genetic Testing: Molecular genetic testing identifies disease-associated variants in Fanconi anemia genes. It helps confirm the diagnosis, identify the genetic subtype, and perform family screening.

4. Bone Marrow Examination: A bone marrow aspiration and biopsy may be performed to assess blood-forming cells, cellularity, and possible abnormalities such as myelodysplastic syndrome or leukemia.

Treatment Options for Fanconi Anemia

Fanconi anemia treatment focuses on maintaining blood cell production, managing complications, and reducing the risk of serious diseases. Treatment decisions depend on blood counts, age, disease severity, and the presence of associated complications.

1. Supportive Treatment: Regular blood count monitoring helps detect declining bone marrow function. Blood transfusions may be needed to manage severe anemia or bleeding-related complications. Antibiotics and other appropriate treatments help manage infections in individuals with low white blood cell counts.

2. Androgen Therapy: Certain androgen medications, such as oxymetholone or danazol, may temporarily improve red blood cell and platelet production in some patients. However, they require careful monitoring because of possible liver complications and other adverse effects.

3. Bone Marrow Transplantation: Bone marrow transplantation is the only established curative treatment for the blood-forming abnormalities of Fanconi anemia. It replaces damaged blood-forming stem cells with healthy donor stem cells.

4. Long-Term Monitoring: Regular surveillance is essential to detect complications early. Monitoring may include blood counts, bone marrow evaluations, endocrine assessments, and examinations for oral, head and neck, skin, and reproductive tract cancers.

Complications and Long-Term Outlook

Fanconi anemia can lead to several serious complications, particularly progressive bone marrow failure. Some individuals develop aplastic anemia, in which the bone marrow cannot produce sufficient blood cells. Others may develop blood and bone marrow cancers.

The condition may also increases endocrine complications and the risk of solid tumors of the head and neck, esophagus, and anogenital region.

Life expectancy varies depending on genetic factors, disease severity, complications, and access to specialized treatment. Early diagnosis, appropriate transplantation when indicated, and lifelong cancer surveillance can improve disease management and outcomes.

Final Takeaways

Fanconi anemia is a complex inherited genetic disorder caused by defects in DNA repair pathways. Although its most significant effects involve bone marrow failure and reduced blood cell production, it can also affect physical development, hormone regulation, and cancer susceptibility. 

There is no single treatment that reverses every feature of Fanconi anemia, but supportive care, androgen therapy, and bone marrow transplantation offer important management options. Lifelong medical follow-up and early detection of complications remain essential for improving the health and quality of life of affected individuals.  

Previous Post Next Post